Elena De Vita. Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivoJ. Acta Pharmaceutica Sinica B, 2025, 15(10): 5491-5492. DOI: 10.1016/j.apsb.2025.09.023
Citation: Elena De Vita. Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivoJ. Acta Pharmaceutica Sinica B, 2025, 15(10): 5491-5492. DOI: 10.1016/j.apsb.2025.09.023
shu

Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivo

    Abstract
    • FullText(HTML)
  • loading
    • References (10)
    • Relative Articles
  • Supplements (0)

Catalog

    Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return